Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 12, 2013, Pages 1239-1246

  Sung, K C ^a   Wild, S H ^b   Byrne, C D ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Atherosclerosis; Cardio metabolic risk factors; Cardiovascular disease (CVD); Coronary artery calcium (CAC) score; Lp(a); Metabolic syndrome (MetS)

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FERRITIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIUM SCORE; DISEASE ASSOCIATION; EXERCISE; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; QUESTIONNAIRE; SMOKING; WAIST CIRCUMFERENCE;

ATHEROSCLEROSIS; BMI; BODY MASS INDEX; CAC; CARDIO-METABOLIC RISK FACTORS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE (CVD); CORONARY ARTERY CALCIUM (CAC) SCORE; CORONARY ARTERY CALCIUM SCORE; CVD; DBP; DIASTOLIC BLOOD PRESSURE; FRAMINGHAM RISK SCORE; FRS; HDLC; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LP(A); METABOLIC SYNDROME; METABOLIC SYNDROME (METS); METS; SBP; SYSTOLIC BLOOD PRESSURE; TG; TRIGLYCERIDE;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; CALCIUM; COHORT STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEIN(A); LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888822590     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.02.009     Document Type: Article

References (29)

1. Utermann G. The mysteries of lipoprotein(a). Science 1989 Nov 17, 246(4932):904-910.
2. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987 Nov 12, 330(6144):132-137.
3. Byrne C.D., Schwartz K., Meer K., Cheng J.F., Lawn R.M. The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver. Arterioscler Thromb 1994 Apr, 14(4):534-541.
4. Spence J.D., Koschinsky M. Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both?. Arterioscler Thromb Vasc Biol 2012 Jul, 32(7):1550-1551.
5. Di A.E., Gao P., Pennells L., Kaptoge S., Caslake M., Thompson A., et al. Lipid-related markers and cardiovascular disease prediction. J Am Med Assoc 2012 Jun 20, 307(23):2499-2506.
6. Clarke R., Peden J.F., Hopewell J.C., Kyriakou T., Goel A., Heath S.C., et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009 Dec 24, 361(26):2518-2528.
7. Kamstrup P.R., Tybjaerg-Hansen A., Nordestgaard B.G. Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis. Arterioscler Thromb Vasc Biol 2012 Jul, 32(7):1732-1741.
8. Bennet A., Di A.E., Erqou S., Eiriksdottir G., Sigurdsson G., Woodward M., et al. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med 2008 Mar 24, 168(6):598-608.
9. Erqou S., Kaptoge S., Perry P.L., Di A.E., Thompson A., White I.R., et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. J Am Med Assoc 2009 Jul 22, 302(4):412-423.
10. Danesh J., Collins R., Peto R. Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies. Circulation 2000 Sep 5, 102:1082-1085.
11. Chien K.L., Hsu H.C., Su T.C., Sung F.C., Chen M.F., Lee Y.T. Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan Community Cardiovascular Cohort Study. Clin Chem 2008 Feb, 54(2):285-291.
12. Banerjee D., Wong E.C., Shin J., Fortmann S.P., Palaniappan L. Racial and ethnic variation in lipoprotein (a) levels among Asian Indian and Chinese patients. J Lipids 2011, 2011:291954.
13. Hoogeveen R.C., Gambhir J.K., Gambhir D.S., Kimball K.T., Ghazzaly K., Gaubatz J.W., et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001 Apr, 42(4):631-638.
14. Virani S.S., Brautbar A., Davis B.C., Nambi V., Hoogeveen R.C., Sharrett A.R., et al. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2012 Jan 17, 125(2):241-249.
15. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet 2011 Sep, 7(9):e1002260.
16. Bhopal R. What is the risk of coronary heart disease in South Asians? A review of UK research. J Public Health Med 2000 Sep, 22(3):375-385.
17. Qi Q., Workalemahu T., Zhang C., Hu F.B., Qi L. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. Eur Heart J 2012 Feb, 33(3):325-334.
18. Budoff M.J., Achenbach S., Blumenthal R.S., Carr J.J., Goldin J.G., Greenland P., et al. Assessment of coronary artery disease by cardiac computed tomography - a scientific statement from the American Heart Association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology. Circulation 2006 Oct 17, 114(16):1761-1791.
19. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National heart, Lung, and blood Institute; American heart association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 Oct 20, 120(16):1640-1645.
20. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary-artery calcium using ultrafast computed-tomography. J Am Coll Cardiol 1990 Mar 15, 15(4):827-832.
21. Rubenfire M., Vodnala D., Krishnan S.M., Bard R.L., Jackson E.A., Giacherio D., et al. Lipoprotein (a): perspectives from a lipid-referral program. J Clin Lipidol 2012 Jan, 6:66-73.
22. Nordestgaard B.G., Chapman M.J., Ray K., Bor+¬n J., Andreotti F., Watts G.F., et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010 Dec, 31(23):2844-2853.
23. Goldhaber S.Z. European Atherosclerosis Society screening recommendations for lipoprotein(a) and high-sensitivity C-reactive protein: double standard or failure of evidence-based medicine?. Clin Chem 2010 Oct, 56(10):1544-1546.
24. Dominiczak M.H., Caslake M.J. Apolipoproteins: metabolic role and clinical biochemistry applications. Ann Clin Biochem 2011 Nov, 48(Pt 6):498-515.
25. Boden W.E., Probstfield J.L., Anderson T., Chaitman B.R., Desvignes-Nickens P., Koprowicz K., et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011 Dec 15, 365(24):2255-2267.
26. Kamstrup P.R., Tybjaerg-Hansen A., Steffensen R., Nordestgaard B.G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. J Am Med Assoc 2009 Jun 10, 301(22):2331-2339.
27. Marcovina S.M., Koschinsky M.L., Albers J.J., Skarlatos S. Report of the National Heart, Lung, and Blood Institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions. Clin Chem 2003 Nov, 49(11):1785-1796.
28. Koschinsky M.L., Marcovina S.M. Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity. Curr Opin Lipidol 2004 Apr, 15(2):167-174.
29. Konerman M., Kulkarni K., Toth P.P., Jones S.R. Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism. J Clin Lipidol 2012 Jan, 6(1):27-32.